[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601758":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":12,"responsibleParty":34,"collaborators":10,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":10,"eligibilityCriteria":43,"healthyVolunteers":40,"sex":44,"minAge":10,"maxAge":10,"enrollmentInfo":45,"targetDuration":10,"studyType":48,"phases":10,"briefSummary":49,"conditions":50,"keywords":52,"overallStatus":15,"whyStopped":10,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"Far Eastern Memorial Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"endometrial cancer",null,"high-risk for reurrence of endometrial cancer.",[13],{"facility":14,"status":15,"city":16,"state":17,"zip":18,"country":19,"countryCode":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital","RECRUITING","Banqiao District","New Taipei","22050","Taiwan","TW",{"type":22,"coordinates":23},"Point",[24,25],121.46719,25.01427,{"lat":25,"lon":24},[28],{"name":29,"role":30,"phone":31,"phoneExt":32,"email":33},"Sheng-Mou Hsiao, MD","CONTACT","+886-2-89667000","1818","smhsiao2@gmail.com",{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Sheng-Mou Hsiao","Chief, Department of Obstetrics & Gynecology","100601758","the-role-of-pole-mutation-in-high-risk-endometrial-cancer-100601758",false,"NCT07114653","The Role of POLE Mutation in High Risk Endometrial Cancer.","Inclusion Criteria:\n\n* women with high-risk for recurrent endometrial cancer\n\nExclusion Criteria:\n\n* Nil","FEMALE",{"count":46,"type":47},150,"ESTIMATED","OBSERVATIONAL","The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is:\n\nWhat is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?",[51],"Endometrial Neoplasms",[53,54],"Endometrial cancer","POLE mutation","2025-08-04",{"date":57,"type":58},"2025-08-11","ACTUAL",{"date":60,"type":47},"2025-09-01",{"date":62,"type":47},"2026-12-31",{"name":5,"class":6},1]